Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. (Q54392848)

29 May 2018

title

Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration. (English)

1 reference

29 May 2018

1 reference

Christian Nischler

1

1 reference

29 May 2018

Hannes Oberkofler

2

1 reference

29 May 2018

Christoph Ortner

3

1 reference

29 May 2018

Doris Paikl

4

1 reference

29 May 2018

Wolfgang Riha

5

1 reference

29 May 2018

Nora Lang

6

1 reference

29 May 2018

Wolfgang Patsch

7

1 reference

29 May 2018

Stefan F Egger

8

1 reference

29 May 2018

publication date

14 January 2011

1 reference

29 May 2018

published in

Acta Ophthalmologica

1 reference

29 May 2018

volume

89

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

e344-9

1 reference

29 May 2018

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H polymorphism and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Prevalence of age-related macular degeneration in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

The genetics of age-related macular degeneration: a review of progress to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H variant increases the risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Genetic risk of age-related maculopathy. Population-based familial aggregation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

The human complement factor H: functional roles, genetic variations and disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Familial aggregation of age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Association between C-reactive protein and age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Risk factors for incident age-related macular degeneration: pooled findings from 3 continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

Complement factor H: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02080.X

10.1111/J.1755-3768.2010.02080.X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

21232084

1 reference

29 May 2018